Keywords: novartis, starts, phase, iii, iloperidone, trials, started

Novartis Starts Phase III Iloperidone Trials

Article | 20 August 1998

Print This

Novartis has started Phase III trials of a novel atypical antipsychotic,iloperidone, which it licenses from Titan Pharmaceuticals in all ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in